News Conference News TCT 2017 Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery Yael L. Maxwell October 31, 2017
News Daily News Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly Michael O'Riordan September 27, 2017
News Conference News TVT 2017 Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line Michael O'Riordan June 20, 2017
News Conference News ACC 2017 SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients Todd Neale March 17, 2017
News Daily News Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib Todd Neale March 15, 2017
News Conference News ISET 2017 Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients Caitlin E. Cox February 06, 2017
News Daily News Readmissions After TAVR Common, With Most Due to Noncardiac Reasons Todd Neale January 06, 2017